SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Trillium Therapeutics
An SI Board Since February 2014
Posts SubjectMarks Bans Symbol
294 39 0 TRIL
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
169<TTI-622, an IgG4 SIRPaFc protein which is primarily being developed for combMiljenko Zuanic13/16/2018
168Does TTI-622 (relative to 621) have option for less frequent dosing (IgG4 ve IgGMiljenko Zuanic-3/15/2018
167TRIL reports 2017 results Trillium Therapeutics Reports Annual 2017 Financial aBladerunner17-3/9/2018
166OT re garbled links: Old SI problem. The links have to be pasted because of thetuck-2/22/2018
165Wow. Don't know why the link gets garbled. Same thing goes for the search scaram(o)uche-2/21/2018
164Authors all from Trillium ("triggers CD47-mediated tumor cell apoptosis&quoscaram(o)uche-2/21/2018
163Overexpression of CD47 involved in abdominal aortic aneurysms scopeblog.stanfordBulbaMan-2/17/2018
162I am not a subscriber to Sally's Blog, biotechstrategyblog.com , though Ighmm-2/7/2018
161Janus Capital files, indicating that they've dropped below 5% ownership. Liscaram(o)uche-2/6/2018
160Same idea, different combo on mice. med.stanford.edusemi_infinite -2/4/2018
159<Might be you really do need to get to close to 100% receptor occupancy to reMiljenko Zuanic12/4/2018
158So dramatic expansion in the size and scope of the intratumoral trials. I reallyBiomaven12/3/2018
157That's right, I should look at the bright side. He's the very best thatscaram(o)uche-1/23/2018
156Who ever is pushing it help me sell my entire position. I am out. Best of luck Miljenko Zuanic-1/23/2018
155"Got to watch for out of context with this cfo" Can you explain this Bladerunner17-1/23/2018
154Someone pushed the bid to 8.90 this morning on arca and picked up a small numberscaram(o)uche-1/23/2018
153THIS is why they have that tacky F-10 out there. If investors/traders can make scaram(o)uche-1/17/2018
152The company also announced that Eric Sievers, MD, has transitioned from Chief Mescaram(o)uche11/17/2018
151"These additions to our management team further bolsters our planned pipeliscaram(o)uche-1/17/2018
150Thank you! Be nice if they published it. Be nice if it was included in datascaram(o)uche-1/16/2018
149I actually asked the company about SLAMF7 last May. They responded that they hadBiomaven-1/16/2018
148Unfortunately, I can't see the figures with sufficient resolution to learn mscaram(o)uche-1/14/2018
147(Published online: January 11, 2018) Accumulating data suggest that SIRPa–CD47 scaram(o)uche11/14/2018
146Mr. James Parsons Chief Financial Officer Mr. Parsons is responsible for financscaram(o)uche-1/12/2018
145When your Business Development team is occupied with revising the header to a S.scaram(o)uche-1/12/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News